Cancer 2019 Dec 1
Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer.
Related Questions
Do prior treatments for mHSPC change your thinking on whether or not to use sipuleucel-T?
New answer by Medical Oncologist at Duke University School of Medicine (August 3, 2021)
I agree. Some of the factors I also use to optimally select patients most likely to have a substantial survival benefit with sip-T are PSA levels (lower levels associated with...